Eli Lilly Hires Denali Therapeutics Executive Carole Ho to Lead Neuroscience Division

Eli Lilly has hired Dr. Carole Ho, formerly chief medical officer and head of development at Denali Therapeutics, as executive vice president and president of Lilly Neuroscience23458.

Carole Ho brings over 20 years of experience in biopharmaceuticals and will also serve on Lilly's Executive Committee23567.

This leadership change is part of Lilly's broader strategy to strengthen its focus on neuroscience, immunology, cardiometabolic health, and oncology2.

At Denali, Ho played a pivotal role in the company's R&D efforts and oversaw significant growth as Denali awaited FDA decisions on key therapies8.

The appointment aligns with Lilly's expansion of its pharmaceutical pipeline and emphasis on improving patient access to medicines256.

Sources:

2. https://www.investing.com/news/company-news/eli-lilly-adds-two-executives-to-leadership-team-amid-pipeline-push-93CH-4340040

3. https://www.europeanpharmaceuticalreview.com/news/267716/lilly-bolsters-leadership-team-with-neuroscience-and-immunology-in-mind/

4. https://www.streetinsider.com/Corporate+News/Lilly+names+new+executives+to+lead+neuroscience+and+immunology+units/25570844.html

5. https://www.nasdaq.com/press-release/lilly-announces-two-new-executive-committee-members-and-expansion-leadership-roles

6. https://www.pharmaindustrial-india.com/news/-eli-lilly-new-executives-senior-leadership-roles-next-phase-of-growth

7. https://www.pharmabiz.com/NewsDetails.aspx?aid=182309&sid=2

8. https://www.bizjournals.com/sanfrancisco/news/2025/11/06/eli-lilly-denali-therapeutics-carole-ho.html